LNWWM
IDXX icon

Laird Norton Wetherby Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$892K Sell
1,396
-62
-4% -$37.6K 0.04% 412
2025
Q2 		$782K Buy
+1,458
New +$697K 0.03% 432
2024
Q4 		$629K Sell
1,522
-304
-17% -$133K 0.03% 456
2024
Q3 		$923K Sell
1,826
-71
-4% -$34.5K 0.04% 381
2024
Q2 		$924K Sell
1,897
-24
-1% -$12K 0.04% 371
2024
Q1 		$1.04M Buy
1,921
+4
+0.2% +$2.19K 0.05% 351
2023
Q4 		$1.06M Sell
1,917
-44
-2% -$20.7K 0.06% 336
2023
Q3 		$857K Sell
1,961
-23
-1% -$11.5K 0.05% 363
2023
Q2 		$996K Sell
1,984
-58
-3% -$27.8K 0.05% 343
2023
Q1 		$1.02M Sell
2,042
-556
-21% -$266K 0.06% 332
2022
Q4 		$1.06M Buy
2,598
+228
+10% +$88.5K 0.07% 312
2022
Q3 		$772K Buy
2,370
+301
+15% +$111K 0.05% 350
2022
Q2 		$726K Sell
2,069
-24
-1% -$9.79K 0.05% 372
2022
Q1 		$1.15M Buy
2,093
+118
+6% +$62.1K 0.07% 277
2021
Q4 		$1.3M Sell
1,975
-32
-2% -$20.1K 0.07% 252
2021
Q3 		$1.25M Buy
2,007
+1
+0% +$672 0.08% 243
2021
Q2 		$1.27M Buy
2,006
+51
+3% +$28.2K 0.08% 244
2021
Q1 		$957K Sell
1,955
-7
-0.4% -$3.51K 0.07% 265
2020
Q4 		$981K Buy
1,962
+8
+0.4% +$3.58K 0.07% 275
2020
Q3 		$768K Sell
1,954
-298
-13% -$110K 0.07% 277
2020
Q2 		$743K Buy
2,252
+112
+5% +$32.4K 0.07% 265
2020
Q1 		$518K Buy
2,140
+196
+10% +$51.2K 0.06% 311
2019
Q4 		$508K Sell
1,944
-165
-8% -$43.5K 0.05% 404
2019
Q3 		$574K Buy
2,109
+115
+6% +$32K 0.06% 358
2019
Q2 		$549K Buy
1,994
+175
+10% +$43.1K 0.06% 367
2019
Q1 		$407K Buy
1,819
+82
+5% +$16.9K 0.05% 418
2018
Q4 		$323K Buy
1,737
+156
+10% +$32K 0.05% 443
2018
Q3 		$395K Sell
1,581
-5
-0.3% -$1.21K 0.05% 420
2018
Q2 		$346K Sell
1,586
-156
-9% -$32.1K 0.05% 432
2018
Q1 		$334K Buy
+1,742
New +$322K 0.05% 449

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's IDXX Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management reduced its Idexx Laboratories (IDXX) stake by 4.3% in Q3 2025, selling an estimated $37.6K and leaving 1,396 shares worth $892K. The position accounts for 0.04% of the portfolio, ranked #412.

Laird Norton Wetherby Wealth Management first reported a position in IDXX in Q1 2018 and has held it in 30 quarters since. The position peaked at $1.3M in Q4 2021. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 1,396 shares of Idexx Laboratories worth $892K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management sold 62 Idexx Laboratories shares in Q3 2025, an estimated $37.6K.
  • Idexx Laboratories made up 0.04% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #412 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 30 quarters since.
  • Laird Norton Wetherby Wealth Management's Idexx Laboratories position peaked at $1.3M in Q4 2021.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.